GEN Exclusives

More »

GEN News Highlights

More »
May 20, 2009

moksha8 Broadens Partnership with Roche to Commercialize More Products in Mexico

  • moksha8 expanded its strategic partnership with Roche to commercialize an additional portfolio of products in Mexico, currently generating sales of $140 million.

    moksha8 will commercialize products in three therapeutic areas—CNS disease, anti-infectives, and inflammation. The product portfolio consists of well-known brands including Rivotril®, Rocephin®, and Bactrim®.

    “moksha8 has established a broad footprint in Latin America, with leading products that are cornerstones of medical care,” said Simba Gill, CEO of moksha8. “We look forward to continuing our strong relationship with Roche and driving value from this important portfolio of products.”



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?